Adma Biologics Inc (ADMA)

EBITDA Margin

45.48%

TTM · Period ending:

ADMA logo

ADMA EBITDA Margin

Latest reported45.48%
ADMA TTM EBITDA Margin (-26951.93% → 45.48%)
High-resolution chart · PNG

ADMA ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Adma Biologics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
45.481%
43.4498%
38.7835%
35.2326%
34.3981%
35.0034%
34.6319%
25.8177%
20.4997%
9.9035%
1.9826%
4.2179%
-4.1469%
-9.964%
-25.6434%
-35.8438%
-47.5185%
-62.948%
-65.5962%
-82.2366%
-96.6139%
-120.7366%
-141.69%
-128.4267%
-126.0156%
-113.9498%
-122.7561%
-209.1979%
-270.008%
-314.6389%
-334.2554%
-206.0748%
-204.774%
-197.1147%
-165.9925%
-222.318%
-173.5712%
-166.5433%
-157.7944%
-172.8974%
-205.0316%
-206.4905%
-211.2335%
-239.8406%
-232.8642%
-226.5033%
-267.4182%
-343.7297%
-352.023%
-449.8977%
-478.8155%
-433.4664%
-576.9704%
-547.7224%
-763.3029%
-846.8174%
-994.3492%
-26,951.9318%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.